IC
LLY icon

Ikarian Capital’s Eli Lilly LLY Stock Holding History

Ikarian Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,547
Closed -$6.02M – 178
2026
Q1 		$6.02M Sell
6,547
-7,268
-53% -$7.37M 0.49% 52
2025
Q4 		$14.8M Buy
+13,815
New +$13.2M 1.16% 24
2023
Q4 		– Sell
-1,227
Closed -$716K – 160
2023
Q3 		$659K Buy
+1,227
New +$632K 0.08% 106
2021
Q3 		– Sell
-5,677
Closed -$1.3M – 243
2021
Q2 		$1.3M Sell
5,677
-119,323
-95% -$24M 0.11% 150
2021
Q1 		$23.4M Buy
+125,000
New +$24.5M 0.79% 30

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ikarian Capital's LLY Position: Q2 2026 in Review

Ikarian Capital sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 6,547 shares — an estimated $6.02M sold.

Ikarian Capital first reported a position in LLY in Q1 2021 and held it in 5 quarters. The position peaked at $23.4M in Q1 2021. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Ikarian Capital reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
  • Ikarian Capital sold 6,547 Eli Lilly shares in Q2 2026, an estimated $6.02M.
  • Ikarian Capital first reported a position in Eli Lilly in Q1 2021 and held it in 5 quarters.
  • Ikarian Capital's Eli Lilly position peaked at $23.4M in Q1 2021.
  • 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Ikarian Capital's 13F filing for Q2 2026, filed 14 Aug 2026.